Blueprint JPM 2025

Blueprint Medicines Driving growth and innovation with operational excellence Kate Haviland, Chief Executive Officer Nearly 15 years of scientific leadership in mast cell biology J.P. Morgan Healthcare Conference January 13, 2025 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding plans, strategies, timelines and expectations for the company ...